240 related articles for article (PubMed ID: 30585960)
1. Radiopharmaceutical Therapy.
Sgouros G
Health Phys; 2019 Feb; 116(2):175-178. PubMed ID: 30585960
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry for radiopharmaceutical therapy.
Sgouros G; Hobbs RF
Semin Nucl Med; 2014 May; 44(3):172-8. PubMed ID: 24832581
[TBL] [Abstract][Full Text] [Related]
4. Radiopeptide imaging and therapy in Europe.
Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
[TBL] [Abstract][Full Text] [Related]
5. Targeted alpha therapy: part I.
Elgqvist J
Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
[TBL] [Abstract][Full Text] [Related]
6.
Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
[TBL] [Abstract][Full Text] [Related]
7. Development of Targeted Alpha Particle Therapy for Solid Tumors.
Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
[TBL] [Abstract][Full Text] [Related]
9. Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.
Kozempel J; Mokhodoeva O; Vlk M
Molecules; 2018 Mar; 23(3):. PubMed ID: 29510568
[TBL] [Abstract][Full Text] [Related]
10. The role of preclinical models in radiopharmaceutical therapy.
Sgouros G; Hobbs RF; Abou DS
Am Soc Clin Oncol Educ Book; 2014; ():e121-5. PubMed ID: 24857091
[TBL] [Abstract][Full Text] [Related]
11. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
Curr Radiopharm; 2017; 10(1):6-15. PubMed ID: 28034291
[TBL] [Abstract][Full Text] [Related]
12. New radiopharmaceutical agents for the treatment of castration-resistant prostate cancer.
Maffioli L; Florimonte L; Costa DC; Correia Castanheira J; Grana C; Luster M; Bodei L; Chinol M
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):420-38. PubMed ID: 26222274
[TBL] [Abstract][Full Text] [Related]
13. Current Status of Radiopharmaceutical Therapy.
St James S; Bednarz B; Benedict S; Buchsbaum JC; Dewaraja Y; Frey E; Hobbs R; Grudzinski J; Roncali E; Sgouros G; Capala J; Xiao Y
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):891-901. PubMed ID: 32805300
[TBL] [Abstract][Full Text] [Related]
14. Peptide receptor imaging and therapy.
Kwekkeboom D; Krenning EP; de Jong M
J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
[TBL] [Abstract][Full Text] [Related]
15. Automated cassette-based production of high specific activity [
Li M; Zhang X; Quinn TP; Lee D; Liu D; Kunkel F; Zimmerman BE; McAlister D; Olewein K; Menda Y; Mirzadeh S; Copping R; Johnson FL; Schultz MK
Appl Radiat Isot; 2017 Sep; 127():52-60. PubMed ID: 28521118
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
17. Dual targeting with
Juzeniene A; Stenberg VY; Bruland ØS; Revheim ME; Larsen RH
Front Med (Lausanne); 2022; 9():1051825. PubMed ID: 36733936
[TBL] [Abstract][Full Text] [Related]
18. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
[TBL] [Abstract][Full Text] [Related]
19. The Case for Dosimetry in Alpha-Emitter Therapy.
Sgouros G
J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S45-S46. PubMed ID: 31537496
[TBL] [Abstract][Full Text] [Related]
20. Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box.
Sgouros G; Frey E; Du Y; Hobbs R; Bolch W
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):18-29. PubMed ID: 34782911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
